Prepubertal octylphenol exposure up-regulate BRCA1 expression, down-regulate ERα expression and reduce rat mammary tumorigenesis

Cancer Epidemiology

Volumn 33, Issue 1, 2009, Pages 51-55

  Peng, Jun Hua ^a   Zhang, Feng ^a   Zhang, Hua Xing ^a   Fan, Hong Yan ^a  

^a LANZHOU GENERAL HOSPITAL   (China)

Author keywords

BRCA1; Breast cancer; ER ; Genistein; Octylphenol

Indexed keywords

BETA ACTIN; BRCA1 PROTEIN; CARCINOGEN; DIMETHYLBENZ[A]ANTHRACENE; ESTROGEN; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; GENISTEIN; MESSENGER RNA; OCTYLPHENOL; PROGESTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SIZE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; DRUG MEGADOSE; ESTROGEN BLOOD LEVEL; FEMALE; NONHUMAN; PERINATAL PERIOD; PREPUBERTY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; RISK REDUCTION; UPREGULATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTICARCINOGENIC AGENTS; BRCA1 PROTEIN; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENISTEIN; MAMMARY NEOPLASMS, ANIMAL; PHENOLS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UP-REGULATION;

EID: 67650066784     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2009.04.017     Document Type: Article

References (48)

1. World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective (1997), American Institute for Cancer Research, Washington, DC
2. Colditz G.A., and Frazier A.L. Models of cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 4 (1995) 567-571
3. Ohayon T., Gershoni B.R., Papa M.Z., Distelman M.T., Eisenberg S., and Friedman E. The R72P P53 mutation is familial breast cancer in Jewish women. Br J Cancer 92 6 (2005) 1144-1148
4. Kelsey J.L., Gammon M.D., and John E.M. Reproductive factors and breast cancer. Epidemiol Rev 15 1 (1993) 36-47
5. Harvell D.M., Strecker T.E., Tochacek M., Xie B., Pennington K.L., McComb R.D., et al. Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc Natl Acad Sci USA 97 6 (2000) 2779-2784
6. Kijkuokool P., Parhar I.S., and Malaivijitnond S. Genistein enhances N-nitrosomethylurea-induced rat mammary tumorigenesis. Cancer Lett 242 1 (2006) 53-59
7. Hertrampf T., Schmidt S., Seibel J., Laudenbach-Leschowsky U., Degen G.H., and Diel P. Effects of genistein on the mammary gland proliferation of adult ovariectomised Wistar rats. Planta Med 72 4 (2006) 304-310
8. Foster W.G., Younglai E.V., Boutross-Tadross O., Hughes C.L., and Wade M.G. Mammary gland morphology in Sprague-Dawley rats following treatment an organochlorine mixture in utero and neonatal genistein. Toxicol Sci 77 1 (2004) 91-100
9. Jonsson F., Wolk A., Pedersen N.L., Lichtenstein P., Terry P., Ahlbom A., et al. Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 106 4 (2003) 594-599
10. Cabanes A., Wang M., Olivo S., DeAssis S., Gustafsson J.A., Khan G., et al. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 25 5 (2004) 741-748
11. Hilakivi-Clarke L., Raygada M., Onojafe I., Cho E., Skaar T., Russo I., et al. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer 80 (1999) 1682-1688
12. Murrill W.B., Brown N.M., Zhang J.X., Manzolillo P.A., Barnes S., and Lamartiniere C.A. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17 (1996) 1451-1457
13. Cotroneo M.S., Wang J., Fritz W.A., Eltoum I.E., and Lamartiniere C.A. Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis 23 (2002) 1467-1474
14. Wu A.H., Wan P., Hankin J., Tseng C.C., Yu M.C., and Pike M.C. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23 (2002) 1491-1496
15. Shaag Y., Jin F., Dai Q., Wen W., Potter J.D., Kushi L.H., et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10 (2001) 483-488
16. Soto A.M., Justicia H., Wray J.W., and Sonnenschein C. p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect 92 (1991) 167-173
17. Nair-Menon J.U., Campbell G.T., and Blake C.A. Toxic effects of octylphenol on cultured rat and murine splenocytes. Toxicol Appl Pharmacol 139 2 (1996) 437-444
18. White R., Jobling S., Hoare S.A., Sumpter J.P., and Parker M.G. Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 135 1 (1994) 175-182
19. Verma S.P., and Goldin B.R. Effect of soy-derived isoflavonoids on the induced growth of MCF-7 cells by estrogenic environmental chemicals. Nutr Cancer 30 3 (1998) 232-239
20. Terasaka S., Inoue A., Tanji M., and Kiyama R. Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity. Toxicol Lett 163 2 (2006) 130-141
21. Aydoǧan M., and Barlas N. Effects of maternal 4-tert-octylphenol exposure on the reproductive tract of male rats at adulthood. Reprod Toxicol 22 3 (2006) 455-460
22. Bøgh I.B., Christensen P., Dantzer V., Groot M., Thøfner I.C., Rasmussen R.K., et al. Endocrine disrupting compounds: effect of octylphenol on reproduction over three generations. Theriogenology 55 1 (2001) 131-150
23. Murono E.P., Derk R.C., and de León J.H. Biphasic effects of octylphenol on testosterone biosynthesis by cultured Leydig cells from neonatal rats. Reprod Toxicol 13 6 (1999) 451-462
24. Aschengrau A., Coogan P.F., Quinn M., and Cashins L.J. Occupational exposure to estrogenic chemicals and the occurrence of breast cancer: an exploratory analysis. Am J Ind Med 34 1 (1998) 6-14
25. Han B.S., Fukamachi K., Takasuka N., Ohnishi T., Maeda M., Yamasaki T., et al. Inhibitory effects s of 17beta-estradiol and octylphenol on 7,12-dimethybenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats. Carcinogenesis 23 7 (2002) 1209-1215
26. Cotroneo M.S., Wang J., Fritz W.A., Eltoum I.E., and Lamartiniere C.A. Genistein action in the prepuertal mammary gland in a chemoprevention model. Carcinogenesis 23 9 (2002) 1467-1474
27. Lamartiniere C.A., Zhang J.X., and Cotroneo M.S. Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. Am J Clin Nutr 68 6 Suppl. (1998) 1400S-1405S
28. Lamartiniere C.A., Murrill W.B., Manzolillo P.A., Zhang J.X., Barnes S., Zhang X., et al. Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc Soc Exp Biol Med 217 3 (1998) 358-364
29. Gudas J.M., Nguyen H., Li T., and Cowan K.H. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 55 (1995) 4561-4565
30. Spillman M., and Bowcock A. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene 13 (1996) 1639-1645
31. Marquis S.T., Rajan J.V., Wynshaw-Boris A., Xu J., Yin G.Y., Abel K.J., et al. The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11 (1995) 17-26
32. Venkitaraman A.R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108 2 (2002) 171-182
33. Garland M., Hunter D.J., Colditz G.A., Manson J.E., Stampfer M.J., Spiegelman D., et al. Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. Am J Epidemiol 147 (1998) 636-643
34. Satagopan J.M., Offit K., Foulkes W., Robson M.E., Wacholder S., et al. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 10 (2001) 467-473
35. Welcsh P.L., Lee M.K., Gonzalez-Hernandez M., and Black J. BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci USA 99 (2002) 7560-7565
36. Fan S., Wang J., Yuan R., Ma Y., Meng Q., Erdos M.R., et al. BRCA1 inhibition of estrogen receptor signalling in transfected cells. Science 284 (1999) 1354-1356
37. Fan S., Ma Y.X., Wang C., Yuan R.Q., Meng Q., Wang J.A., et al. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 20 (2001) 77-87
38. Tyl R.W., Myers C.B., Marr M.C., Brine D.R., Fail P.A., Seely J.C., et al. Two-generation reproduction study with para-tert-octylphenol in rats. Regul Toxicol Pharmacol 30 2 Pt 1 (1999) 81-95
39. Yoshida M., Katsuda S., Ando J., Kuroda H., Takahashi M., and Maekawa A. Subcutaneous treatment of p-tert-octylphenol exerts estrogenic activity on the female reproductive tract in normal cycling rats of two different strains. Toxicol Lett 116 1/2 (2000) 89-101
40. Pedersen R.T., and Hill E.M. Tissue distribution and depuration of 4-tert-octylphenol residues in the cyprinid fish, Scardinius erythrophthalmus. Environ Sci Technol 36 15 (2002) 3275-3283
41. Korach K.S. Insights from the study of animals lacking functional estrogen receptor. Science 266 5190 (1994) 1524-1527
42. Osborne C.K. Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51 3 (1998) 227-238
43. Lawson J.S., Field A.S., Champion S., Tran D., Ishikura H., and Trichopoulos D. Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer incidence in Japan. Lancet 354 (1999) 1787-1788
44. Razandi M., Pedram A., Rosen E.M., and Levin E.R. BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 24 13 (2004) 5900-5913
45. Hilakivi C.L. Estrogens BRCA1 and breast cancer risk. Cancer Res 60 (2000) 4993-5001
46. Zheng W., Luo F., Lu J.J., Baltayan A., Press M.F., Zhang Z.F., et al. Reduction of BRCA1 expression in sporadic ovarian cancer. Gynecol Oncol 76 3 (2000) 294-300
47. Thompson M.E., Jensen R.A., Obermiller P.S., Page D.L., and Holt J.T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9 4 (1995) 444-450
48. Ozçelik H., To M.D., Couture J., Bull S.B., and Andrulis I.L. Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. Int J Cancer 77 1 (1998) 1-6